Cargando…

Rethinking cancer clinical trials for COVID-19 and beyond

The risks posed to patients with cancer by the current COVID-19 pandemic demand rapid structural changes in healthcare delivery, with many positive changes likely to continue long term. An immediate critical reassessment of trial methodology based on clinical and scientific priorities is essential t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doherty, Gary J., Goksu, Mehmet, de Paula, Bruno H. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258610/ https://www.ncbi.nlm.nih.gov/pubmed/35121973 http://dx.doi.org/10.1038/s43018-020-0083-x

Ejemplares similares

Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic
por: de Paula, Bruno H R, et al.
Publicado: (2020)

Long COVID-19: Rethinking mental health
por: Gallegos, Miguel, et al.
Publicado: (2022)

Rethinking sepsis after a two-year battle with COVID-19
por: Zhang, Yingying, et al.
Publicado: (2022)

Radioactivity to Rethink the Earth's Energy Balance
por: Terranova, Maria Letizia
Publicado: (2021)

Rethinking vaccine hesitancy among minority groups
por: Khan, Mishal S, et al.
Publicado: (2021)

Towards pandemic preparedness beyond COVID-19
por: Naguib, Mahmoud M, et al.
Publicado: (2020)

Participant stress in the COVID-19 era and beyond
por: Goldfarb, Elizabeth V.
Publicado: (2020)

Protection against COVID-19: beyond antibodies
por: Lacerda, Marcus Vinícius Guimarães, et al.
Publicado: (2022)

Oculoplastic video-based telemedicine consultations: Covid-19 and beyond
por: Kang, Swan, et al.
Publicado: (2020)

Beyond the tip of the iceberg: direct and indirect effects of COVID-19
por: Kaczorowski, Janusz, et al.
Publicado: (2021)

Beyond COVID-19—will self-sampling and testing become the norm?
por: Boum, Yap, et al.
Publicado: (2021)

Clinical trials of disease stages in COVID 19: complicated and often misinterpreted
por: Park, Jay J H, et al.
Publicado: (2020)

SARS-CoV-2 transmission: time to rethink public health strategy
por: Parker, Arifa, et al.
Publicado: (2022)

Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election
por: Strathdee, Steffanie A, et al.
Publicado: (2020)

Mental health of homeless people in China amid and beyond COVID-19
por: Su, Zhaohui, et al.
Publicado: (2022)

Migration and health in Latin America during the COVID-19 pandemic and beyond
por: Bojorquez, Ietza, et al.
Publicado: (2021)

US COVID-19 clinical trial leadership gender disparities
por: Sehgal, Neil K R, et al.
Publicado: (2023)

Time to press the reset button—can we use the COVID-19 pandemic to rethink the process of transplant assessment?
por: Kumar, Mukesh, et al.
Publicado: (2021)

Public health surveillance of infectious diseases: beyond point mutations
por: Goodman, Laura B, et al.
Publicado: (2021)

Plant Solutions for the COVID-19 Pandemic and Beyond: Historical Reflections and Future Perspectives
por: Weng, Jing-Ke
Publicado: (2020)

Social vulnerability indices: A pragmatic tool for COVID-19 policy and beyond
por: Mah, Jasmine C., et al.
Publicado: (2022)

It is never too late to rethink serum folate()
por: Fertrin, Kleber Yotsumoto
Publicado: (2018)

The COVID-19 pandemic: a catalyst to improve clinical trials
por: Gaba, Prakriti, et al.
Publicado: (2020)

Rethinking COVID-19 and Beyond: Prevention, Remedies, and Recovery
por: Maffetone, Philip B., et al.
Publicado: (2022)

Variability in counselling for adrenal insufficiency in COVID-19 and beyond: a survey of rheumatology practice
por: Mehta, Puja, et al.
Publicado: (2021)

COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties
por: Kuderer, Nicole M, et al.
Publicado: (2022)

Challenges in operationalising clinical trials in India during the COVID-19 pandemic
por: Bassi, Abhinav, et al.
Publicado: (2022)

Controlled obesity status: a rarely used concept, but with particular importance in the COVID-19 pandemic and beyond
por: Halpern, B., et al.
Publicado: (2020)

Challenges for the female health-care workers during the COVID-19 pandemic: the need for protection beyond the mask
por: Crimi, Claudia, et al.
Publicado: (2021)

Early-phase clinical trials in a pandemic: learning from the response to COVID-19
por: Horsley, Alex, et al.
Publicado: (2022)

Key clinical research priorities for the pediatric community during the COVID-19 pandemic
por: Noel, Gary J., et al.
Publicado: (2020)

The effects of antihypertensive medications on severity and outcomes of COVID19
por: Agirbasli, Mehmet
Publicado: (2022)

Stewardship of COVID-19 volunteers by nested trial design
por: Gottlieb, Robert L, et al.
Publicado: (2022)

COVID-19, community trials, and inclusion
por: Gill, Paramjit S, et al.
Publicado: (2021)

Clinical exome sequencing in daily practice: 1,000 patients and beyond
por: van Zelst-Stams, Wendy A, et al.
Publicado: (2014)

Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism
por: Otu, Akaninyene, et al.
Publicado: (2021)

Preliminary results of a clinical study to evaluate the performance and safety of swallowing in critical patients with COVID-19
por: de Lima, Maíra Santilli, et al.
Publicado: (2020)

Circular RNAs as promising biomarkers in cancer: detection, function, and beyond
por: Li, Shengli, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on clinical research
por: Tuttle, Katherine R.
Publicado: (2020)

Beyond bar charts
por: Saxon, Emma
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_60hl5a50eb6mcpavsm16kibsat